China Biotech I-Mab Is Said to Target Up to $500 Million in IPO

The Shanghai-based company plans to submit an application to the Hong Kong stock exchange next week, the people said, asking not to be identified because the information is confidential. I-Mab aims to …
( read original story …)


Related Post